- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 228
Aspen Technology snaps up Mnubo
Aspen has agreed to buy the Munich RE-backed IoT data analytics provider in a deal worth $78.2m, weeks after acquiring Sabisu's digital workspace platform.
Jul 19, 2019Daily deal net: July 18, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jul 18, 2019Woodford prepares biotech clearance
Woodford Investment Management will auction unlisted biotech investments which include Oxford Nanopore in a process that could take three months to reach its conclusion.
Jul 18, 2019Douyu wins $775m IPO game
Tencent-backed Douyu has successfully listed on Nasdaq after completing a $775m initial public offering that came after economic tensions forced a delay earlier this year.
Jul 18, 20198x8 locks in Wavecell acquisition
8x8 has acquired cloud-based communications technology provider Wavecell in a $125m cash and stock deal, allowing Telkom Indonesia's MDI Ventures to exit.
Jul 18, 2019Visa pins in Payworks purchase
Visa has acquired the cloud-based payment processing software provider Payworks, one of its portfolio companies, also handing an exit to Commerzbank.
Jul 18, 2019CloudMinds seeks $500m IPO
SoftBank is the largest shareholder in CloudMinds, owning more than a third of the AI and robotics technology developer that is targeting an overseas listing in the US.
Jul 17, 2019Tendril teams up with Simple Energy
Engie, SunPower, Siemens and GE-backed Tendril Networks has joined forces with Simple Energy to create a utility software provider called Uplight.
Jul 16, 2019Blackstone eyes Vungle acquisition
Blackstone has agreed to buy the in-app advertising platform, in a reported $750m deal that will see Alphabet and Verizon exit.
Jul 16, 2019Amal advances to $365m acquisition
Boehringer Ingelheim will pay a total of up to $365m to acquire its venture fund's portfolio company Amal Therapeutics, an immunotherapy spinout of University of Geneva.
Jul 16, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


